Connected Clinical Workflows for Rare Disease Research
Founded from a mission to make rare disease and orphan drug clinical trials more accessible, Jeeva supports research teams through connected workflows designed to improve patient engagement, decentralized participation, and modern clinical trial execution.
Problem
We Understand Rare Disease Patient Journey and Trial Challenges
01
Limited Patient Recruitment
Support broader participant recruitment through connected engagement workflows and decentralized participation across global rare disease studies.
04
Regulatory Compliance
Maintain compliant clinical trial workflows through centralized documentation, tracking, and operational visibility across global research environments.
02
Geographic Dispersion of Participants
Enable remote participation and connected communication workflows that reduce travel burden and improve accessibility for geographically dispersed participants.
05
Patient Engagement and Retention
Keep participants engaged through connected communication, reminders, scheduling, and multilingual engagement workflows across long-duration studies.
03
Complex Data Management
Support centralized collection and coordination of clinical, genetic, laboratory, and participant-reported data across connected study workflows.
06
Limited Access to Experts and Resources
Support collaboration across research teams, sites, and participants through connected virtual workflows and decentralized clinical trial participation.
Problem
We Understand Rare Disease Patient Journey and Trial Challenges
01
Limited Patient Recruitment
Support broader participant recruitment through connected engagement workflows and decentralized participation across global rare disease studies.
03
Complex Data Management
Support centralized collection and coordination of clinical, genetic, laboratory, and participant-reported data across connected study workflows.
05
Patient Engagement and Retention
Keep participants engaged through connected communication, reminders, scheduling, and multilingual engagement workflows across long-duration studies.
02
Geographic Dispersion of Participants
Enable remote participation and connected communication workflows that reduce travel burden and improve accessibility for geographically dispersed participants.
04
Regulatory Compliance
Maintain compliant clinical trial workflows through centralized documentation, tracking, and operational visibility across global research environments.
06
Limited Access to Experts and Resources
Support collaboration across research teams, sites, and participants through connected virtual workflows and decentralized clinical trial participation.
Problem
We Understand Rare Disease Patient Journey and Trial Challenges
01
Limited Patient Recruitment
Support broader participant recruitment through connected engagement workflows and decentralized participation across global rare disease studies.
02
Geographic Dispersion of Participants
Enable remote participation and connected communication workflows that reduce travel burden and improve accessibility for geographically dispersed participants.
03
Complex Data Management
Support centralized collection and coordination of clinical, genetic, laboratory, and participant-reported data across connected study workflows.
04
Regulatory Compliance
Maintain compliant clinical trial workflows through centralized documentation, tracking, and operational visibility across global research environments.
05
Patient Engagement and Retention
Keep participants engaged through connected communication, reminders, scheduling, and multilingual engagement workflows across long-duration studies.
06
Limited Access to Experts and Resources
Support collaboration across research teams, sites, and participants through connected virtual workflows and decentralized clinical trial participation.
Patient Journey with a Rare Disease
Solutions
Our Solutions for Rare Disease Clinical Research
Customized Workflows for Unique Trials
Accelerated Recruitment
Configure connected clinical workflows designed to support the unique protocols, participant journeys, and operational requirements of rare disease studies.
Accelerated Study Startup
Flexible & Accessible Participation
Simplify study setup and operational coordination to help research teams launch rare disease trials more efficiently.
Reduced Data Errors Through Automation
Flexible Study Configuration
Support accurate and centralized data collection through automated workflows designed to reduce manual coordination and improve operational consistency.
Connected Remote Data Collection
Improve Retention & Participant Engagement
Enable participants to securely contribute clinical and patient-reported data remotely across decentralized and geographically dispersed study environments.
Jeeva Benefits
Launch rare disease clinical trials in less than four weeks
Up to 3X faster to first patient first visit (FPFV) across study execution
Access connected workflows securely across browser-based devices
Real-time centralized monitoring and operational visibility
Premium 24/7 study support for research teams
Reduce logistical burden on study teams by over 70%
Connect sites, coordinators, and participants across global clinical trial operations
Clients Love Jeeva Solutions
Compliance Programs Supported
FAQ
We Hear You Loud and Clear! Clearing Up Your Oncology Research Concerns
How does Jeeva support the recruitment of patients with rare diseases?
Can Jeeva's software be customized for unique rare disease trials?
How does Jeeva reduce data errors in rare disease trials?
What options does Jeeva provide for remote data collection?
How quickly can a study be launched with Jeeva's software?
How does Jeeva ensure compliance with global regulatory standards for rare disease trials?
We already have some of our own tools internally or some third-party vendor contracts.
We’re not ready to invest in new platforms.
We’re too small to need something like this.
How do we know it’s compliant?
How does Jeeva support the recruitment of patients with rare diseases?
Jeeva leverages virtual recruitment tools to connect with a global network of patients, making it easier to find and engage individuals with rare diseases, no matter how geographically dispersed they are.
Can Jeeva's software be customized for unique rare disease trials?
Absolutely. Jeeva’s platform is designed to be flexible and customizable, allowing researchers to tailor the software to the specific protocols and requirements of each rare disease study.
How does Jeeva reduce data errors in rare disease trials?
Jeeva reduces data errors through automated data entry and management processes, which help ensure that the data collected is consistent, accurate, and reliable, minimizing human errors.
What options does Jeeva provide for remote data collection?
Participants can easily report data via Jeeva’s platform using their personal devices, enabling real-time and mobile data collection. This capability is particularly beneficial for rare disease trials with patients in diverse locations.
How quickly can a study be launched with Jeeva's software?
Jeeva facilitates a quick and efficient study setup, minimizing administrative delays. This means your rare disease trials can be launched within four weeks, allowing researchers to focus their efforts on vital study activities.
How does Jeeva ensure compliance with global regulatory standards for rare disease trials?
Jeeva’s built-in compliance features and comprehensive documentation tools support adherence to varying global regulatory requirements, helping researchers navigate the complex regulatory landscape of rare disease clinical trials confidently and effectively.
We already have some of our own tools internally or some third-party vendor contracts.
You may derive most value when your clinical operations infrastructure is not set up yet. However, even if some of your infrastructure is in place, Jeeva can complement what you have with modularity and automation.
We’re not ready to invest in new platforms.
There’s no upfront CapEx. Our pricing is usage-based, and partners see ROI by reducing site coordination and compliance overhead.
We’re too small to need something like this.
That’s exactly why sponsors and CROs with team sizes under 50 people love Jeeva. You get big CRO capabilities without the cost or complexity.
How do we know it’s compliant?
Jeeva is fully validated, GCP-aligned, 21 CFR Part 11 and GDPR compliant. We’re already used by academic medical centers and sponsors in regulated trials.
Testimonials
Client Testimonials
There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.
Frank Sasinowski, JD, MPH
A Legendary Leader in Rare Diseases and Orphan Drugs Regulation
We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders
Dr. Terry Jo Bichell
CombinedBrain
Jeeva's easy-to-use software interfaces and detailed user manual are backed by outstanding support team! Jeeva's technology platform enables us to serve patients globally in their native language.
Nisha Venugopal, Ph.D
Associate Director, Patient Focused Research Programs, Indo US Organization for Rare Diseases
Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.
Marshall Summar, MD, Ph.D
CEO, Uncommon Cures LLC
Having evaluated numerous clinical trial platforms, Jeeva was refreshing in its vision to engage underrepresented minorities, focus on rare diseases, and collaborative approach beyond technology. We are eager to enable patient education, recruitment, and retention in rare disease clinical studies such as patient registries and cell/gene therapies.
Sara Tylosky, CEO
CEO, Farmacon Global
There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.
Frank Sasinowski, JD, MPH
A Legendary Leader in Rare Diseases and Orphan Drugs Regulation
We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders
Dr. Terry Jo Bichell
CombinedBrain
Jeeva's easy-to-use software interfaces and detailed user manual are backed by outstanding support team! Jeeva's technology platform enables us to serve patients globally in their native language.
Nisha Venugopal, Ph.D
Associate Director, Patient Focused Research Programs, Indo US Organization for Rare Diseases
